Skip to content

Medical-device intelligence

DHX: System, Test, Carcinoembryonic Antigen

FDA product code DHX: System, Test, Carcinoembryonic Antigen. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
DHX
FDA device name
System, Test, Carcinoembryonic Antigen
Device class
2
Regulation number
866.6010
Medical specialty
Immunology
Review panel
IM

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore immunology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

28 clearance records and 9 recall records in the covered releases, across 27 source company names and 1 product codes. Dated history runs from Sep 26, 1980 to Sep 22, 2023.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
DHX · System, Test, Carcinoembryonic Antigen289

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

37 matching records
Device / recordCompany in FDA recordSourceSource date
Access CEAK223921 · DHXBeckman Coulter, Inc.510(k)Sep 22, 2023FDA decision date
VITROS Immunodiagnostic Products CEA Reagent PackK231517 · DHXOrtho Clinical Diagnostics510(k)Aug 23, 2023FDA decision date
ADVIA Centaur CEA AssayK200215 · DHXSiemens Healthcare Disgnostics, Inc.510(k)Apr 13, 2020FDA decision date
ST-AIA PACK CEA; Part Number: 025254 Assay, Tumor MarkerZ-2066-2018 · DHXTosoh Bioscience IncRecallJun 5, 2018FDA record creation date
IMMULITE /IMMULITE 1000 CEAZ-1678-2018 · DHXSiemens Healthcare Diagnostics, Inc.RecallMay 4, 2018FDA classification date
IMMULITE 2000/IMMULITE 2000 XPi CEAZ-1679-2018 · DHXSiemens Healthcare Diagnostics, Inc.RecallMay 4, 2018FDA classification date
Access CEA Assay, Part No. 33200. For the quantitative determination of Carcinoembryonic Antigen (CEA) levels in human serum.Z-0239-2016 · DHXBeckman Coulter Inc.RecallNov 6, 2015FDA classification date
CEA ELISA Kit. BioCheck, Foster City, CA 9440. Quantitative determination of AFP concentration in human serum.Z-1627-2011 · DHXBioCheck IncRecallMar 11, 2011FDA classification date
OLYMPUS CEA - CARCINOEMBRYONIC ANTIGENK081615 · DHXOlympus America, Inc.510(k)Mar 18, 2009FDA decision date
VIDAS CEA (S) ASSAYK080194 · DHXbioMerieux, Inc.510(k)Oct 9, 2008FDA decision date
DIMENSION VISTA CARCINOEMBRYONIC ANTIGEN FLEX REAGENT CARTRIDGE (CEA)K071603 · DHXDade Behring, Inc.510(k)Jun 25, 2008FDA decision date
Access Immunoassay system CEA, in vitro diagnostic, Part No. 33200Z-1313-06 · DHXBeckman Coulter IncRecallAug 1, 2006FDA classification date
Immulite/ Immulite 1000 Carcinoembryonic Antigen (CEA) LKCE1 lot 302 and 303Z-1015-05 · DHXDiagnostic Products CorpRecallJul 16, 2005FDA classification date
Immulite 1000 CEA Catalog No. LKCE1Z-0972-04 · DHXDiagnostic Products CorpRecallJul 20, 2004FDA classification date
VITROS IMMUNODIAGNOSTIC PRODUCTS CEA REAGENT PACK/CALIBRATOR/RANGE VERIFIERSK041322 · DHXOrtho-Clinical Diagnostics, Inc.510(k)Jun 17, 2004FDA decision date
Vitros Immunodiagnostic Products CEA REAGENT PACK, Lot 750, REF 192 0115, 100 coated wells per pack. Firm on the label: Ortho-Clinical Diagnost…Z-0299-04 · DHXOrtho-Clinical DiagnosticsRecallJan 6, 2004FDA classification date
ACCESS CEA REAGENTS FOR USE ON THE ACCESS IMMUNOASSAY SYSTEMSK031270 · DHXBeckman Coulter, Inc.510(k)May 6, 2003FDA decision date
ST AIA-PACK CEA ENZYME IMMUNOASSAYK023893 · DHXTosoh Medics, Inc.510(k)Dec 18, 2002FDA decision date
CEA ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEMK013568 · DHXBayer Corp.510(k)Dec 21, 2001FDA decision date
VITROS IMMUNODIAGNOSTIC PRODUCTS CEA CALIBRATORS, VITROS IMMUNODIAGNOSTIC PRODUCTS CEA REAGENT PACKK990943 · DHXOrtho-Clinical Diagnostics, Inc.510(k)Jun 1, 1999FDA decision date
MODIFICATION TO ACCESS CEA REAGENTS FOR USE ON THE ACCESS IMMUNOASSAY ANALYZER, MODELS 33200, 33205, 33209, 33206K991707 · DHXBeckman510(k)Jun 1, 1999FDA decision date
ABBOTT ARCHITECT CEAK990774 · DHXAbbott Laboratories510(k)May 11, 1999FDA decision date
ACCESS CEA REAGENTS ON THE ACCESS IMMUNOASSAY ANALYZER MODEL 33200, 33205, 33206 & 33209K981985 · DHXBeckman Coulter, Inc.510(k)Sep 24, 1998FDA decision date
ACS:CENTAUR CEAK981478 · DHXChiron Diagnostics Corp.510(k)Aug 12, 1998FDA decision date
ELECSYS CEA ON THE ELECSYS 1010K980887 · DHXBoehringer Mannheim Corp.510(k)Jun 29, 1998FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗